Daily non-political popular news in brief.
Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
10-30-2006 · EurekAlert!Mayo Clinic Cancer Center has opened a new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme, a largely untreatable brain tumor.
Read more »
Keywords: mayo, clinic, cancer, center, harnessing, measles, virus, attack, measle, viru
« Previous | Next »
Similar news on "Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer":
- Investigating the measles virus as a tool to kill multiple myeloma
03-05-2007 · EurekAlert!
Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure.
Similar news · Read more »
- Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
04-15-2007 · EurekAlert!
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study, being presented today at the American Association for Cancer Research annual meeting, show the by-product to be more effective than currently used therapies at killing multiple myeloma cells.
Similar news · Read more »
- Mayo Clinic Cancer Center -- individualizing treatment for multiple myeloma patients
12-10-2006 · EurekAlert!
Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.
Similar news · Read more »
- Mayo Clinic Cancer Center -- Working on the tough cases
12-11-2006 · EurekAlert!
Mayo Clinic Cancer Center, in collaboration with researchers from the University of Iowa, today presented results of a Phase II clinical study indicating that an oral drug, tipifarnib, can stall or reverse disease progression for patients with relapsed aggressive non-Hodgkin lymphoma.
Similar news · Read more »
- Mayo Clinic-led study improves breast cancer risk prediction in women with Atypia
06-29-2007 · EurekAlert!
Women with at least three sites of cellular atypia in breast tissue are nearly eight times more likely than average women to develop breast cancer, according to findings of a Mayo Clinic Cancer Center-led study of women with atypical hyperplasia.
Similar news · Read more »
- Researchers train the immune system to deliver virus that destroys cancer in lab models
12-18-2007 · EurekAlert!
An international team of researchers led by Mayo Clinic have designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system.
Similar news · Read more »
- Multiple myeloma clinical trial closes early
04-04-2007 · EurekAlert!
Mayo Clinic Cancer Center announced today that a multiple myeloma clinical trial has shown a significant improvement in survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone.
Similar news · Read more »
- A discovery that may lessen a health disparity
04-17-2007 · EurekAlert!
Mayo Clinic Cancer Center scientists, in collaboration with Chinese researchers, have isolated an enzyme that could be used to predict survival and recurrence rates for nasopharyngeal cancer -- a common cancer affecting people from Southeast Asia.
Similar news · Read more »
- Mayo Clinic Cancer Center -- Surgery and adjuvant therapy may work for pancreatic cancer
01-20-2007 · EurekAlert!
In the largest single-institution retrospective study to date, researchers at Mayo Clinic Cancer Center have shown that giving patients both radiation and chemotherapy after completely removing invasive pancreatic cancer may improve overall survival rates.
Similar news · Read more »
- Mayo Clinic Cancer Center collaborating to find new tools to fight leukemia
12-10-2006 · EurekAlert!
Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL).
Similar news · Read more »
